The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term treatment with testosterone undecanoate injections and its effect of prostate cancer incidence in hypogonadal men.
Ahmad Haider
Honoraria - Bayer; Jenapharm ; Takeda
Research Funding - Bayer
Other Remuneration - Bayer; Takeda
Michael Zitzmann
Consultant or Advisory Role - Lilly
Honoraria - Bayer; Besins Healthcare; Lilly
Research Funding - Bayer
Other Remuneration - Bayer; Lilly
Aksam Yassin
Honoraria - Bayer; Ferring
Research Funding - Bayer
Other Remuneration - Bayer; Teva